Skip to content

Study on the mechanism of auricular acupoint affecting the outcome of IVF in patients with anxiety

Study on the theory of renal main reproduction based on the global regulation network of differential proteins and metabolites in IVF follicular fluid

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026848
Enrollment
Unknown
Registered
2019-10-24
Start date
2019-11-22
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Sponsors

Shandong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
23 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. Aged 23-37 years, junior high school education level or above, in line with the diagnosis of infertility. 2. IVF/ICSI assisted pregnancy due to female fallopian tube factors or male factors, using luteal short-term and long-term regimens. 3. Ensure that the patient is free of uterine structural disorders, systemic diseases and external ear health, that the patient has not recently been diagnosed with anxiety disorder, or that he has not received any anxiety treatment before. 4. Informed consent, volunteer.

Exclusion criteria

Exclusion criteria: 1. Complicated with immune diseases, infectious diseases, severe heart diseases and chronic wasting diseases; endometriosis; chromosome abnormalities; polycystic ovary syndrome. 2. Previous history of ovarian surgery, previous history of radiotherapy and chemotherapy, hysteroscopy showed weak uterine lesions, mania, depression, or schizophrenia accompanied by anxiety. 3. The patients with mental depression caused by hyperthyroidism, hypertension, coronary heart disease, drug dependence or other mental nerve diseases were excluded. Those who have serious adverse events in the course of research and treatment and are not suitable to continue to participate in the experiment are excluded. 4. To eliminate the withdrawal response of excitatory drug overdose, hypnotic sedative or anti-anxiety drugs, and to eliminate obsessive-compulsive disorder, fear, hypochondria, dysmenorrhea, mania and depression. Or schizophrenia and other concomitant anxiety.

Design outcomes

Primary

MeasureTime frame
Levels of norepinephrine, cortisol, IL-6, IL-1 ß, tumor necrosis factor a (TNF- a) and neuropeptide Y in follicular fluid and serum;Clinical indicators of IVF (total use of Gn, days of Gn use, egg recovery rate, fertilization rate, cleavage rate, high quality embryo rate, clinical pregnancy rate);

Secondary

MeasureTime frame
Number of pregnancies, education, address, occupation, infertility years, scale scores;

Countries

China

Contacts

Public ContactSun Zhengao

Shandong Provincial Traditional Chinese Medicine Reproductive Center

sunzhengao77@163.com+86 13708938621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026